Latest Skystar Bio-Pharmaceutical Company (SKBI) Headlines
Uptrend Call Working As Skystar Bio-Pharmaceutical Stock Rises 29.4% (SKBI)
Comtex SmarTrend(R) - Wed Mar 12, 11:01AM CDT
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 4 weeks, Skystar Bio-Pharmaceutical has returned 29.39% as of today's recent price of $5.90.
40.1% Return Seen to Date on SmarTrend Skystar Bio-Pharmaceutical Call (SKBI)
Comtex SmarTrend(R) - Wed Mar 05, 9:38AM CST
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 3 weeks, Skystar Bio-Pharmaceutical has returned 40.13% as of today's recent price of $6.39.
Shares of SKBI Up 22.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 26, 9:15AM CST
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 2 weeks, Skystar Bio-Pharmaceutical has returned 22.81% as of today's recent price of $5.60.
5 Stocks Ready to Explode Higher
at The Street - Wed Feb 12, 1:13PM CST
These stocks could be sett9ing up for explosive moves higher soon.
4 Biotech Stocks Under $10 Making Big Moves
at The Street - Wed Jan 29, 6:00AM CST
Keep these under-$10 biotech stocks on your radar.
Skystar Bio-Pharmaceutical posts increased net income of USD3.7m in Q3 2013
M2 - Mon Nov 18, 3:06AM CST
Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, on Friday reported unaudited net income of USD3.7m, or USD0.49 per fully diluted share, for the third quarter of fiscal year 2013, ended 30 September 2013.
Skystar Bio-Pharmaceutical Reports Third Quarter 2013 Results
Marketwire - Fri Nov 15, 4:00AM CST
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, today reported unaudited third quarter fiscal year 2013 earnings, for the period ended September 30, 2013.
Skystar Bio-Pharmaceutical to Host Third Quarter 2013 Earnings Webcast Live on Friday, November 15, 2013
ACCESSWIRE - Thu Nov 14, 8:36AM CST
XI'AN, CHINA - (ACCESSWIRE - November 14, 2013) - Skystar Bio-Pharmaceutical Company (SKBI) will host a live webcast to discuss the results of the third quarter 2013, to be held Friday, November 15, 2013 at 7:45 a.m. Eastern Time.
Skystar to File Financial Results for Third Quarter of Fiscal 2013 on Thursday, November 14, 2013
Marketwire - Thu Nov 14, 8:30AM CST
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the third quarter of fiscal 2013 on Thursday November 14, 2013 by close of the business day.
Skystar Bio-Pharmaceutical Reports Second Quarter 2013 Results
Marketwire - Wed Aug 14, 2:00PM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today reported unaudited second quarter fiscal year 2013 earnings, for the period ended June 30, 2013.
Skystar to File Financial Results for Second Quarter of Fiscal 2013 on Wednesday, August 14, 2013
Marketwire - Tue Aug 13, 4:00PM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the second quarter of fiscal 2013 on Wednesday August 14, 2013 at close of the business day.
Market Maker Surveillance Report. CIEN, CHTP, NLST, SKBI, MY, NPTN, Winning Stocks With Lowest Price Friction For Thursday, June 6th 2013
M2 - Fri Jun 07, 3:00AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3815 companies with "abnormal" market making, 3439 companies with positive Friction Factors and 1883 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Ciena Corp (NASDAQ:CIEN), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), Netlist Inc (NASDAQ:NLST), Skystar Bio Pharmaceutical Co (NASDAQ:SKBI), China Ming Yang Wind Power Group Ltd (NYSE:MY), NeoPhotonics Corp (NYSE:NPTN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Skystar Bio-Pharmaceutical Company posts lower net income of USD0.7m for Q1 2013
M2 - Fri May 17, 6:43AM CDT
Veterinary medicine company Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) stated on Thursday its net income of USD0.7m or USD0.09 per fully diluted share, for the first quarter fiscal year 2013.
Skystar Bio-Pharmaceutical Reports First Quarter 2013 Results
Marketwire - Thu May 16, 4:00AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, today reported unaudited first quarter fiscal year 2013 earnings, for the fiscal period ended March 31, 2013.
Skystar to File Financial Results for First Quarter of 2013 on Wednesday, May 15, 2013
Marketwire - Tue May 14, 8:03AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the first quarter of the fiscal year 2013 on Wednesday May 15, 2013 at the end of the business day.
Skystar Bio-Pharmaceutical Reports Fiscal Year 2012 Financial Results
Marketwire - Tue Apr 02, 4:00AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced full financial results for fiscal year ended December 31, 2012.
Skystar to File Audited Financial Results for Full Fiscal Year 2012 on Monday April 1, 2013
Marketwire - Mon Apr 01, 8:01AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its audited financial results for the full fiscal year 2012 on Monday April 1, 2013 at the end of the business day.
MGN, SKBI, ZEP, GBF, MNOV, PYS Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Mar 27, 7:52AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Mines Management Inc (AMEX:MGN), Skystar Bio Pharmaceutical Co (NASDAQ:SKBI), Zep Inc (NYSE:ZEP), iShares Barclays Government/Credit Bond Fund (NYSE:GBF), MediciNova Inc (NASDAQ:MNOV), PPLUS Trust Series RRD-1 (NYSE
YS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Skystar Bio-Pharmaceutical Engages Protiviti, a Leading Provider of Consulting and Internal Audit Services
Marketwire - Tue Mar 26, 8:01AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, announced that on March 14, 2013 the Company engaged Protiviti, a leading provider of consulting and internal audit services, whose expertise will serve to extend Skystar's accounting team's knowledge of rules on internal controls, procedures and reporting related to U.S. listing.
JAG, SKBI, SHV, MAXY, SFNC, IAI Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Jan 23, 7:53AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Jaguar Mining Inc (NYSE:JAG), Skystar Bio Pharmaceutical Co (NASDAQ:SKBI), iShares Barclays Short Treasury Bond Fund (NYSE:SHV), Maxygen Inc (NASDAQ:MAXY), SIMMONS FIRST NATIONAL CORPORATION (NASDAQ:SFNC), iShares Dow Jones US Broker-Dealers Index Fund (NYSE:IAI) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Uptrend Call Working As Skystar Bio-Pharmaceutical Stock Rises 29.4% (SKBI)
Comtex SmarTrend(R) - Wed Mar 12, 11:01AM CDT
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 4 weeks, Skystar Bio-Pharmaceutical has returned 29.39% as of today's recent price of $5.90.
40.1% Return Seen to Date on SmarTrend Skystar Bio-Pharmaceutical Call (SKBI)
Comtex SmarTrend(R) - Wed Mar 05, 9:38AM CST
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 3 weeks, Skystar Bio-Pharmaceutical has returned 40.13% as of today's recent price of $6.39.
Shares of SKBI Up 22.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 26, 9:15AM CST
SmarTrend identified an Uptrend for Skystar Bio-Pharmaceutical (NASDAQ:SKBI) on February 11th, 2014 at $4.56. In approximately 2 weeks, Skystar Bio-Pharmaceutical has returned 22.81% as of today's recent price of $5.60.
5 Stocks Ready to Explode Higher
at The Street - Wed Feb 12, 1:13PM CST
These stocks could be sett9ing up for explosive moves higher soon.
4 Biotech Stocks Under $10 Making Big Moves
at The Street - Wed Jan 29, 6:00AM CST
Keep these under-$10 biotech stocks on your radar.
Skystar Bio-Pharmaceutical posts increased net income of USD3.7m in Q3 2013
M2 - Mon Nov 18, 3:06AM CST
Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, on Friday reported unaudited net income of USD3.7m, or USD0.49 per fully diluted share, for the third quarter of fiscal year 2013, ended 30 September 2013.
Skystar Bio-Pharmaceutical Reports Third Quarter 2013 Results
Marketwire - Fri Nov 15, 4:00AM CST
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, today reported unaudited third quarter fiscal year 2013 earnings, for the period ended September 30, 2013.
Skystar Bio-Pharmaceutical to Host Third Quarter 2013 Earnings Webcast Live on Friday, November 15, 2013
ACCESSWIRE - Thu Nov 14, 8:36AM CST
XI'AN, CHINA - (ACCESSWIRE - November 14, 2013) - Skystar Bio-Pharmaceutical Company (SKBI) will host a live webcast to discuss the results of the third quarter 2013, to be held Friday, November 15, 2013 at 7:45 a.m. Eastern Time.
Skystar to File Financial Results for Third Quarter of Fiscal 2013 on Thursday, November 14, 2013
Marketwire - Thu Nov 14, 8:30AM CST
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the third quarter of fiscal 2013 on Thursday November 14, 2013 by close of the business day.
Skystar Bio-Pharmaceutical Reports Second Quarter 2013 Results
Marketwire - Wed Aug 14, 2:00PM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today reported unaudited second quarter fiscal year 2013 earnings, for the period ended June 30, 2013.
Skystar to File Financial Results for Second Quarter of Fiscal 2013 on Wednesday, August 14, 2013
Marketwire - Tue Aug 13, 4:00PM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the second quarter of fiscal 2013 on Wednesday August 14, 2013 at close of the business day.
Market Maker Surveillance Report. CIEN, CHTP, NLST, SKBI, MY, NPTN, Winning Stocks With Lowest Price Friction For Thursday, June 6th 2013
M2 - Fri Jun 07, 3:00AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3815 companies with "abnormal" market making, 3439 companies with positive Friction Factors and 1883 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Ciena Corp (NASDAQ:CIEN), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), Netlist Inc (NASDAQ:NLST), Skystar Bio Pharmaceutical Co (NASDAQ:SKBI), China Ming Yang Wind Power Group Ltd (NYSE:MY), NeoPhotonics Corp (NYSE:NPTN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Skystar Bio-Pharmaceutical Company posts lower net income of USD0.7m for Q1 2013
M2 - Fri May 17, 6:43AM CDT
Veterinary medicine company Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) stated on Thursday its net income of USD0.7m or USD0.09 per fully diluted share, for the first quarter fiscal year 2013.
Skystar Bio-Pharmaceutical Reports First Quarter 2013 Results
Marketwire - Thu May 16, 4:00AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, today reported unaudited first quarter fiscal year 2013 earnings, for the fiscal period ended March 31, 2013.
Skystar to File Financial Results for First Quarter of 2013 on Wednesday, May 15, 2013
Marketwire - Tue May 14, 8:03AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the first quarter of the fiscal year 2013 on Wednesday May 15, 2013 at the end of the business day.
Skystar Bio-Pharmaceutical Reports Fiscal Year 2012 Financial Results
Marketwire - Tue Apr 02, 4:00AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced full financial results for fiscal year ended December 31, 2012.
Skystar to File Audited Financial Results for Full Fiscal Year 2012 on Monday April 1, 2013
Marketwire - Mon Apr 01, 8:01AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its audited financial results for the full fiscal year 2012 on Monday April 1, 2013 at the end of the business day.
MGN, SKBI, ZEP, GBF, MNOV, PYS Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Mar 27, 7:52AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Mines Management Inc (AMEX:MGN), Skystar Bio Pharmaceutical Co (NASDAQ:SKBI), Zep Inc (NYSE:ZEP), iShares Barclays Government/Credit Bond Fund (NYSE:GBF), MediciNova Inc (NASDAQ:MNOV), PPLUS Trust Series RRD-1 (NYSE
YS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: Skystar Bio-Pharmaceutical Engages Protiviti, a Leading Provider of Consulting and Internal Audit Services
Marketwire - Tue Mar 26, 8:01AM CDT
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, announced that on March 14, 2013 the Company engaged Protiviti, a leading provider of consulting and internal audit services, whose expertise will serve to extend Skystar's accounting team's knowledge of rules on internal controls, procedures and reporting related to U.S. listing.
JAG, SKBI, SHV, MAXY, SFNC, IAI Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Jan 23, 7:53AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Jaguar Mining Inc (NYSE:JAG), Skystar Bio Pharmaceutical Co (NASDAQ:SKBI), iShares Barclays Short Treasury Bond Fund (NYSE:SHV), Maxygen Inc (NASDAQ:MAXY), SIMMONS FIRST NATIONAL CORPORATION (NASDAQ:SFNC), iShares Dow Jones US Broker-Dealers Index Fund (NYSE:IAI) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
